![]()
SEPT/OCT 2008 |
SRNT NewsletterSEPTEMBER/OCTOBER 2008, Volume 14, Number 3 Nicotine Research Grant Funding UpdateThe Tobacco and Nicotine Research Interest Group (TANRIG) consists of representatives from the NIH, CDC, and other DHHS agencies who seek to increase collaboration, coordination and communication of tobacco- and nicotine-related research across NIH Institutes and Centers and with other DHHS agencies. The TANRIG is co-chaired by Allison Chausmer (NIDA) and Ed Trapido (NCI) who can provide additional information about TANRIG. The National Cancer Institute recently published the 19th edition of the tobacco control monograph series entitled The Role of Media in Promoting and Reducing Tobacco Use. Monograph 19 is the most current and comprehensive distillation of the scientific literature on media communications in tobacco promotion and tobacco control. It synthesizes the science across the disciplines of marketing, psychology, communications, statistics, epidemiology, and public health. It is hoped that the key lessons from this monograph can inform policymakers as well as scientists and practitioners. The monograph is available online and can be ordered at http://www.cancercontrol.cancer.gov/tcrb/monographs/19/index.htm. Numerous Funding Opportunity Announcements (FOAs) of potential interest to tobacco researchers have been released recently. Note that there may be additional mechanisms available, but only one mechanism for each announcement is listed below.
· Measures and Determinants of Smokeless Tobacco Use, Prevention, and
Cessation (R01). This funding opportunity announcement (FOA) encourages the submission
of research grant applications from scientists who propose to study the factors that
mediate initiation, use, and cessation of smokeless tobacco, to understand the relationship
of smokeless tobacco with other tobacco products, and to develop methods for
studying smokeless tobacco products and related behaviors in humans. The overall goal is
to develop an evidence base to inform smokeless tobacco control efforts, and to
develop effective ways to limit the spread and promote cessation of smokeless tobacco use.
· Improving Effectiveness of Smoking Cessation Interventions and Programs
in Low Income Adult Populations (R01). This funding opportunity announcement
(FOA) encourages research grant applications for projects designed to improve outcomes
of smoking cessation in low income adult populations within the United States.
Despite significant progress in reducing the prevalence of smoking in the United States,
smoking continues to represent a major threat to public health. In addition, decreases in
smoking have not been consistent across the population and marked disparities exist with
smoking prevalence continuing to remain high among low income adults. The long-term goal is
to facilitate a significant reduction in smoking prevalence among low income adults,
thereby reducing the excess disease burden of tobacco use within these groups and decreasing
the prevalence of smoking in the United States as a whole. This FOA is intended to
support human research only.
· Economics of Treatment and Prevention Services for Drug & Alcohol Abuse
(R01). This Funding Opportunity Announcement (FOA) encourages Research Project Grant
(R01) applications on the economics of prevention and treatment services for drug and
alcohol abuse. Such research projects might emphasize any of the following subjects: (1)
financing and purchasing of drug and alcohol treatment and prevention services, including studies
of health insurance and payment mechanisms; (2) economic incentives used to improve
the quality and economic efficiency of treatment and prevention services (3) alternative
delivery systems and managed care; (4) cost-benefit, cost-effectiveness, or cost-utility analyses;
(5) service costs, production, and economic efficiency; and (6) research to develop or
improve methods to be used in the economic study of drug and alcohol services.
· Functional Characterization of Genetic Variants and Interactions: The Genes,
Environment and Health Initiative (R21). This FOA supports research relating genetic
variation to biological mechanism, or disease causality. Areas of interest include, but are
not limited to, relatively low throughput approaches (e.g. transgenic mouse approaches) to
test some of the most promising variants for changes in function; or exploit high-throughput
tests (e.g. yeast, C. elegans, cell culture systems, or computational approaches) to look at
different aspects of variant function.
· Genome-wide Association Studies of Treatment Response in Randomized
Clinical Trials _ Study Investigators (U01). The purpose of this funding opportunity is to
support genome-wide association (GWA) studies in randomized controlled clinical trials to
identify genetic variants associated with response to treatments for conditions of clinical or
public health significance.
· Integration of Mouse Models into Human Cancer Research
(U01). This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI),
extends the NCI-Mouse Models of Human Cancers Consortium (NCI-MMHCC) for a third
project period. The previous periods resulted in generation, validation, and utilization of many
novel mouse cancer models. Having successfully attained the original specific program goals,
the NCI-MMHCC is poised to enter the next stage that stresses the use of biologically
relevant mouse models as effective tools for human research.
· Reducing Risk Behaviors by Promoting Positive Youth Development (R01). The purpose of this Funding Opportunity Announcement is to encourage Research Project
Grant (R01) applications from institutions/ organizations that propose to enhance our
understanding of effective positive youth development programs and the mechanisms responsible for
positive health and developmental outcomes. This will be accomplished through the
development, implementation, and evaluation of new or improved positive youth development
programs, the evaluation of existing "successful" programs, or the evaluation of effective,
evidence-based, gender-inclusive programs that are adapted, translated, or disseminated
for new populations of youth and adolescents.
· Small Grants Program for Cancer Epidemiology
(R03). This funding opportunity announcement (FOA) encourages the submission of Small Research Grant (R03)
applications for research on cancer etiology and epidemiology. The overarching goal of this
FOA is to provide support for pilot projects, testing of new techniques, secondary analyses
of existing data, development and validation of measurement methods, linkage of
genetic polymorphisms with other variables related to cancer risk, and development of
innovative projects for more comprehensive research in cancer etiology and epidemiology.
· Using Systems Science Methodologies to Protect and Improve Population
Health (R21). This FOA solicits Exploratory/Developmental (R21) applications from
institutions/organizations that propose to apply one or more specific system science methodologies
to public health and health care systems problems and contribute knowledge that will
enhance effective decision making around the development of and prioritization of
policies, interventions, and programs to improve population health, especially where resources
are limited and only a limited number of programs/policies/interventions can be
implemented. Applicants are encouraged to submit projects that tackle "policy resistant" health
problems (i.e., ones in which the effects of planned interventions, programs or policies tend
to be delayed, diluted or defeated by responses of the system to the intervention itself)
using a systems science methodology.
· Fogarty International Research Collaboration _ Behavioral and Social
Sciences (FIRCA-BSS) Research Award (R03). This Funding Opportunity Announcement (FOA) facilitates collaborative behavioral and social sciences research between
scientists supported by the National Institutes of Health (NIH) and investigators in low- and
middle-income countries (LMIC). Special consideration will be given to proposed research
that addresses significant global health problems, particularly those of high relevance to
an LMIC country or region.
· Methodology and Measurement in the Behavioral and Social Sciences
(R01). The goal of this Funding Opportunity Announcement (FOA) is to encourage research that
will improve the quality and scientific power of data collected in the behavioral and
social sciences, relevant to the missions of the participating NIH Institutes and Centers.
· Technological Innovations for Interdisciplinary Research Incorporating the
Behavioral and Social Sciences (SBIR
[R43/R44]). The purpose of this Funding Opportunity Announcement (FOA) is to solicit Small Business Innovation Research (SBIR)
grant applications from small business concerns (SBCs) for development of new,
innovative technologies for research integrating human social and/or behavioral science with
other disciplines.
|
|